id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-E-4700-0008,FDA,FDA-2015-E-4700,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2019-03-08T05:00:00Z,2019,3,2019-03-08T05:00:00Z,,2019-03-08T12:55:01Z,,0,0,0900006483acc285
FDA-2015-E-4700-0007,FDA,FDA-2015-E-4700,"Determination of Regulatory Review Period for Purposes of Patent
Extension; ESBRIET",Notice,Determinations,2018-02-22T05:00:00Z,2018,2,2018-02-22T05:00:00Z,2018-04-24T03:59:59Z,2018-02-22T19:28:43Z,2018-03612,0,0,0900006482f53b4c
FDA-2015-E-4700-0005,FDA,FDA-2015-E-4700,Letter from CDER to U.S. Patent and Trademark Office,Other,Letter(s),2017-05-12T04:00:00Z,2017,5,2017-05-12T04:00:00Z,,2017-05-12T18:23:44Z,,0,0,09000064825ae035
FDA-2015-E-4700-0006,FDA,FDA-2015-E-4700,Regulatory Review Letter,Other,Letter(s),2017-05-12T04:00:00Z,2017,5,2017-05-12T04:00:00Z,,2017-05-12T22:07:52Z,,0,0,09000064825aff35
FDA-2015-E-4700-0004,FDA,FDA-2015-E-4700,Letter from U.S. Patent and Trademark Office to FDA,Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T16:17:38Z,,0,0,090000648243452c
FDA-2015-E-4700-0003,FDA,FDA-2015-E-4700,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2016-01-26T05:00:00Z,2016,1,2016-01-26T05:00:00Z,,2016-01-26T13:42:31Z,,0,0,0900006481e252dd
FDA-2015-E-4700-0002,FDA,FDA-2015-E-4700,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2015-12-09T05:00:00Z,2015,12,2015-12-09T05:00:00Z,,2015-12-09T16:05:32Z,,0,0,0900006481d92c36
FDA-2015-E-4700-0001,FDA,FDA-2015-E-4700,"Patent Extension Application from Marshall, Gerstein & Borun, LLP (on behalf of InterMune, Inc.)",Other,Application,2015-12-09T05:00:00Z,2015,12,2015-12-09T05:00:00Z,,2015-12-10T13:40:59Z,,0,0,0900006481d9300e